423 related articles for article (PubMed ID: 12107207)
1. Cardiovascular consequences of early-onset growth hormone excess.
Colao A; Spinelli L; Cuocolo A; Spiezia S; Pivonello R; di Somma C; Bonaduce D; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2002 Jul; 87(7):3097-104. PubMed ID: 12107207
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly.
Colao A; Marzullo P; Ferone D; Spinelli L; Cuocolo A; Bonaduce D; Salvatore M; Boerlin V; Lancranjan I; Lombardi G
J Clin Endocrinol Metab; 2000 Sep; 85(9):3132-40. PubMed ID: 10999798
[TBL] [Abstract][Full Text] [Related]
3. Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly.
Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Florimonte L; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 1999 Jan; 84(1):17-23. PubMed ID: 9920056
[TBL] [Abstract][Full Text] [Related]
4. Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance.
Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Della Morte AM; Pivonello R; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2001 Apr; 86(4):1551-7. PubMed ID: 11297582
[TBL] [Abstract][Full Text] [Related]
5. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
[TBL] [Abstract][Full Text] [Related]
6. Impact of patient's age and disease duration on cardiac performance in acromegaly: a radionuclide angiography study.
Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Della Morte AM; Petretta M; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 1999 May; 84(5):1518-23. PubMed ID: 10323372
[TBL] [Abstract][Full Text] [Related]
7. Cardiac effect of thyrotoxicosis in acromegaly.
Marzullo P; Cuocolo A; Ferone D; Pivonello R; Salvatore M; Lombardi G; Colao A
J Clin Endocrinol Metab; 2000 Apr; 85(4):1426-32. PubMed ID: 10770177
[TBL] [Abstract][Full Text] [Related]
8. Impaired cardiac performance in elderly patients with growth hormone deficiency.
Colao A; Cuocolo A; Di Somma C; Cerbone G; Della Morte AM; Nicolai E; Lucci R; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 1999 Nov; 84(11):3950-5. PubMed ID: 10566633
[TBL] [Abstract][Full Text] [Related]
9. Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly.
Colao A; Spiezia S; Cerbone G; Pivonello R; Marzullo P; Ferone D; Di Somma C; Assanti AP; Lombardi G
Clin Endocrinol (Oxf); 2001 Apr; 54(4):515-24. PubMed ID: 11318788
[TBL] [Abstract][Full Text] [Related]
10. Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide.
Colao A; Marzullo P; Cuocolo A; Spinelli L; Pivonello R; Bonaduce D; Salvatore M; Lombardi G
Clin Endocrinol (Oxf); 2003 Feb; 58(2):169-76. PubMed ID: 12580932
[TBL] [Abstract][Full Text] [Related]
11. Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency.
Colao A; Di Somma C; Cuocolo A; Spinelli L; Acampa W; Spiezia S; Rota F; Savanelli MC; Lombardi G
J Clin Endocrinol Metab; 2005 Sep; 90(9):5146-55. PubMed ID: 15985481
[TBL] [Abstract][Full Text] [Related]
12. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study.
Colao A; di Somma C; Pivonello R; Cuocolo A; Spinelli L; Bonaduce D; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2002 Mar; 87(3):1088-93. PubMed ID: 11889170
[TBL] [Abstract][Full Text] [Related]
13. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency.
Colao A; di Somma C; Cuocolo A; Spinelli L; Tedesco N; Pivonello R; Bonaduce D; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2001 May; 86(5):1874-81. PubMed ID: 11344175
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly.
Colao A; Ferone D; Marzullo P; Cappabianca P; Cirillo S; Boerlin V; Lancranjan I; Lombardi G
J Clin Endocrinol Metab; 2001 Jun; 86(6):2779-86. PubMed ID: 11397887
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency.
Colao A; Di Somma C; Filippella M; Rota F; Pivonello R; Orio F; Vitale G; Lombardi G
Clin Endocrinol (Oxf); 2004 Sep; 61(3):360-6. PubMed ID: 15355453
[TBL] [Abstract][Full Text] [Related]
16. Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy.
Colao A; Baldelli R; Marzullo P; Ferretti E; Ferone D; Gargiulo P; Petretta M; Tamburrano G; Lombardi G; Liuzzi A
J Clin Endocrinol Metab; 2000 Jan; 85(1):193-9. PubMed ID: 10634386
[TBL] [Abstract][Full Text] [Related]
17. The GH-IGF-I axis and the cardiovascular system: clinical implications.
Colao A
Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular diastolic function and cardiac performance during exercise in patients with acromegaly.
Spinelli L; Petretta M; Verderame G; Carbone G; Venetucci AA; Petretta A; Acampa W; Bonaduce D; Colao A; Cuocolo A
J Clin Endocrinol Metab; 2003 Sep; 88(9):4105-9. PubMed ID: 12970271
[TBL] [Abstract][Full Text] [Related]
19. Treatment with growth hormone receptor antagonist in acromegaly: effect on cardiac structure and performance.
Pivonello R; Galderisi M; Auriemma RS; De Martino MC; Galdiero M; Ciccarelli A; D'Errico A; Kourides I; Burman P; Lombardi G; Colao A
J Clin Endocrinol Metab; 2007 Feb; 92(2):476-82. PubMed ID: 17105844
[TBL] [Abstract][Full Text] [Related]
20. The cardiovascular risk of GH-deficient adolescents.
Colao A; Di Somma C; Salerno M; Spinelli L; Orio F; Lombardi G
J Clin Endocrinol Metab; 2002 Aug; 87(8):3650-5. PubMed ID: 12161490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
